Biohaven Pharmaceutical Holding Co Ltd.

WELLINGTON MANAGEMENT GROUP LLP

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

13,280

Value ($000)

2,008

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	2,008	0.0%	13,280	9/30/2022
2022 Q2	8/15/2022	1,600	0.0%	10,984	6/30/2022
2022 Q1	5/16/2022	16,041	0.0%	135,284	3/31/2022
2021 Q4	2/11/2022	14,036	0.0%	101,847	12/31/2021
2021 Q3	11/15/2021	14,034	0.0%	101,032	9/30/2021
2021 Q2	8/16/2021	26,876	0.0%	276,842	6/30/2021
2021 Q1	5/17/2021	124,079	0.0%	1,815,354	3/31/2021
2020 Q4	2/12/2021	135,958	0.0%	1,586,252	12/31/2020
2020 Q3	11/16/2020	152,163	0.0%	2,340,609	9/30/2020
2020 Q2	8/14/2020	152,315	0.0%	2,083,381	6/30/2020
2020 Q1	5/14/2020	106,120	0.0%	3,118,373	3/31/2020
2019 Q4	2/11/2020	83,821	0.0%	1,539,665	12/31/2019